Clinical Trial

Developing Biomarker-Supported Schizophrenia Spectrum Disorder (SSD) Prevention

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to compare the effect of a brief family-based psychosocial intervention that addresses modifiable SSD risk factors on persistent and distressing psychotic-like experiences in children and young adults with a family history of SSD and high versus low baseline SSD-like brain patterns
Trial Details
NCT Number NCT07743645
Lead Sponsor The University of Texas Health Science Center, Houston
Collaborators: National Institutes of Health (NIH)
Conditions Prevention, Risk Factors for Mental Illness, Family History of Schizophrenia Spectrum Disorder
Enrollment 100 participants
Start Date 2026-10-01
Primary Completion 2031-04-01 (estimated)
Study Completion 2031-04-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-04